Figure 3: Rates of asthma quality-of-care indicators in Saskatchewan in 2003/04. All rates, except crude overall rates, were adjusted using the indicator denominator population (Table 1). Residents with registered Indian status were excluded from our study. Of the cases identified in 2002/03 (26 616), 24 180 were eligible for inclusion in 2003/04. *Adjusted for sex. †Adjusted for age. ‡Adjusted for age and sex. §Significantly different (p < 0.05) from the rate across all other categories within the variable group. ¶At least moderate inhaled corticosteroid use was defined as ≥ 251 μg/d for fluticasone and beclomethasone-HFA, ≥ 501 μg/d for beclomethasone-CFC and budesonide nebulizer solution, ≥ 1001 μg/d for beclomethasone dry powder inhaler, ≥ 401 μg/d for budesonide inhaler. Note: CI = confidence interval, NR = not reported (owing to a sample size of less than 6).